Netenax (Netilmicin)

Netilmicin, the active ingredient in Netenax, is an aminoglycoside antibiotic presented as an ophthalmic solution for ocular use. It is indicated for the treatment of bacterial conjunctivitis, keratitis and other bacterial infections of the eye in patients requiring topical therapy. The product complies with EU regulatory standards and is manufactured under strict GMP conditions.

GNH USA supplies Netenax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured ophthalmic antibiotics for global markets.

Netenax is used in ophthalmology to treat bacterial infections of the eye.

Bacterial conjunctivitis: reduces bacterial load and alleviates inflammation in the conjunctival sac. Keratitis: eradicates causative bacteria and promotes corneal healing. Other ocular bacterial infections: provides broad‑spectrum coverage against susceptible Gram‑negative and Gram‑positive organisms.

Adverse reactions to Netenax are generally limited to the eye and surrounding tissues.

Common Side Effects: - Eye irritation: transient burning or stinging upon instillation - Redness: mild conjunctival hyperemia - Blurred vision: temporary visual disturbance - Tearing: increased lacrimation

Serious or Rare Side Effects: - Corneal ulceration: rare severe corneal damage - Allergic reaction: swelling, itching, or rash around the eye - Vision loss: extremely rare irreversible visual impairment

When using Netenax, consider the following precautions.

Allergy assessment: confirm no known hypersensitivity to aminoglycosides Contact lens use: avoid wearing lenses until treatment completed Concurrent ocular medications: evaluate for potential additive irritation Pregnancy and lactation: use only if benefits outweigh risks, as safety data are limited Monitoring: observe for signs of worsening infection or allergic response Store at room temperature: keep in original container, protect from light and moisture

Potential drug interactions with Netenax should be reviewed before therapy.

Major Interactions (Avoid): - Nephrotoxic systemic aminoglycosides: concurrent use may increase systemic absorption risk - Ototoxic drugs: risk of systemic ototoxicity if significant absorption occurs

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may reduce antibacterial efficacy - Non‑steroidal anti‑inflammatory eye drops: monitor for increased irritation - Systemic diuretics: monitor renal function if systemic absorption suspected